BASF: Crédit Suisse raises target price
(CercleFinance.com) - Crédit Suisse maintains its 'neutral' rating on the BASF share, albeit raising its target price to 59 euros compared to 56 euros previously.
The analyst expects an increase to EBIT of 12% for the 2020 financial year and 9% for 2021/2022, in line with the results expected for the 3rd quarter, in particular cash flows of 3.2 billion euros.
Strategically, Crédit Suisse expects the emphasis to be placed on portfolio development in the medium term, and indicates that the refocus on composite activity could suggest that other fields may see divestment (construction chemicals, pigments etc.).
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The analyst expects an increase to EBIT of 12% for the 2020 financial year and 9% for 2021/2022, in line with the results expected for the 3rd quarter, in particular cash flows of 3.2 billion euros.
Strategically, Crédit Suisse expects the emphasis to be placed on portfolio development in the medium term, and indicates that the refocus on composite activity could suggest that other fields may see divestment (construction chemicals, pigments etc.).
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.